Suppr超能文献

Biodistribution-Driven Discovery Identifies a Glycosidase-Cleavable Linker to Reprogram Radiotheranostics.

作者信息

Lee Woonghee, Doda Sai Reddy, Baidoo Kwamena E, Nambiar Divya, Chung Joon-Yong, Adler Stephen, Edmondson Elijah, Ueda Yuki, Omiya Satoshi, Li Xiaoyi, Makala Hima, Sheehan-Klenk Julia, Fayn Stanley, Weiss Orit Jacobson, Lindberg Eric, Beck Jessica A, LeBlanc Amy K, Lin Frank I, Choyke Peter L, Swenson Rolf, Schnermann Martin J, Escorcia Freddy E

机构信息

Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Bethesda, MD 20895, USA.

Chemical Synthesis Center, National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda, MD 20895, USA.

出版信息

bioRxiv. 2025 Sep 16:2025.09.11.675134. doi: 10.1101/2025.09.11.675134.

Abstract

While radiopharmaceutical therapy (RPT) has become part of the standard-of-care for patients with advanced prostate cancers and neuroendocrine tumors (NETs), cures are elusive and normal tissue toxicity remain a challenge. Chemical groups susceptible to cleavage by enzymes present in tumors, tumor microenvironment or in normal tissues, have the potential to improve the therapeutic index for RPT. Using DOTA-TATE as an example and drawing from strategies used to develop antibody-drug conjugates, we designed, and synthesized, a chemically diverse series of linkers between the chelator (DOTA) and the targeting vector (TATE). Of the 10 agents we tested, two with cleavable linker domains reduced kidney retention compared to DOTA-TATE: the previously reported DOTA-MVK(ε)-TATE, and a novel agent bearing cleavable beta-galactose (β-Gal) unit, DOTA-β-Gal-TATE. In murine models of NETs, positron emission tomography (PET) was used to image yttrium-86 (Y)-labeled variants and show that, while the Y-DOTA-MVK(ε)-TATE exhibits similar tumor uptake to the parent non-cleavable Y-DOTA-TATE, Y-DOTA-β-Gal-TATE shows enhanced tumor uptake, resulting in up to 10-fold improvement in the tumor-to-kidney ratios compared to Y-DOTA-TATE. and studies confirm high efficiency, enzyme-specific cleavage of Y-DOTA-MVK(ε)-TATE and Y-DOTA-β-Gal-TATE, supporting a key role for cleavable linker chemistry in the observed outcomes. RPT studies using actinium-225 (Ac)-labeled variants confirm that all agents are therapeutically effective and well tolerated. While both cleavable variants exhibit superior local control, overall survival, and more favorable toxicity profile when compared with Ac-DOTA-TATE, Ac-DOTA-β-Gal-TATE demonstrated lower nephrotoxicity. Our findings suggest a potentially generalizable strategy for improving the pharmacokinetics of radiopharmaceutical therapy agents.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9168/12458472/bb239a5fc4da/nihpp-2025.09.11.675134v1-f0001.jpg

本文引用的文献

1
Development of Novel Radiotheranostic Ligand with Positively Charged Unit Targeting Prostate-Specific Membrane Antigen.
J Med Chem. 2025 May 22;68(10):10190-10202. doi: 10.1021/acs.jmedchem.5c00370. Epub 2025 May 13.
3
Evaluation of the Gly-Phe-Lys Linker to Reduce the Renal Radioactivity of a [Cu]Cu-Labeled Multimeric cRGD Peptide.
ACS Omega. 2025 Jan 24;10(4):4102-4120. doi: 10.1021/acsomega.4c10621. eCollection 2025 Feb 4.
5
First-in-human validation of enzymolysis clearance strategy for decreasing renal radioactivity using modified [Ga]Ga-HER2 Affibody.
Eur J Nucl Med Mol Imaging. 2024 May;51(6):1713-1724. doi: 10.1007/s00259-023-06584-8. Epub 2024 Jan 13.
6
Exploring the next generation of antibody-drug conjugates.
Nat Rev Clin Oncol. 2024 Mar;21(3):203-223. doi: 10.1038/s41571-023-00850-2. Epub 2024 Jan 8.
7
MIRD Pamphlet No. 28, Part 1: MIRDcalc-A Software Tool for Medical Internal Radiation Dosimetry.
J Nucl Med. 2023 Jul;64(7):1117-1124. doi: 10.2967/jnumed.122.264225. Epub 2023 Jun 2.
8
Glycosidase activated prodrugs for targeted cancer therapy.
Chem Soc Rev. 2022 Nov 28;51(23):9694-9716. doi: 10.1039/d2cs00379a.
10
A Primer on Radiopharmaceutical Therapy.
Int J Radiat Oncol Biol Phys. 2023 Jan 1;115(1):48-59. doi: 10.1016/j.ijrobp.2022.08.010. Epub 2022 Aug 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验